Save the Date | August 1-3, 2024 | ProSleep 2024 Users Conference | Fairmont Hotel, San Francisco, CA | Early Bird Registration Coming Soon!
Healthcare Providers
Find a Provider

About ProSomnus Sleep Technologies

ProSomnus (NASDAQ: OSA) is the leading non-CPAP OSA therapy™ for the treatment of Obstructive Sleep Apnea, a serious medical disease affecting over 1 billion people worldwide, that is associated with comorbidities including heart failure, stroke, hypertension, morbid obesity, and type 2 diabetes. ProSomnus intraoral medical devices are engineered to precisely track the treatment plan and anatomy for each patient. Non-invasive, patient preferred and easy to use, ProSomnus devices have demonstrated excellent efficacy, safety, adherence, and overall outcomes in a growing body of clinical investigations. ProSomnus precision intraoral devices are FDA-cleared, patented, and covered by commercial medical insurance, Medicare, TRICARE and many Government sponsored healthcare plans around the world, representing over 200 million covered lives. To find a provider near you, visit https://prosomnus.com/find-a-provider/.

Executive Team

Len Liptak

Co-founder &
Chief Executive Officer

Sung Kim

Co-founder &
Chief Technology Officer

Brian Dow

Chief Financial Officer

Mark T. Murphy, DDS

Lead Faculty Clinical Education

Heather Whalen

Vice President, Global Marketing
Services

Jerry Vogel

Vice President, Sales Trainer

Medical & Scientific Leadership

John E. Remmers, MD

Chief Scientist

Edward T. Sall, MD, DDS

Medical Director

Mark T. Murphy, DDS

Lead Faculty Clinical Education

Shouresh Charkhandeh, DDS

Global Scientific Committee Chair

Erin Mosca, PhD

Director of Scientific and Medical Affairs

Board of Directors

Len Liptak

Chief Executive Officer, Co-founder, and Director

Laing Rikkers

Executive Chair, Director, and Co-founder

Len Hedge

Director

Heather Rider

Director

Bill Johnson

Director and Chairman

Steven Pacelli

Director and Chairman

Jason Orchard

Director

Board of Directors

Laing Rikkers, Chairwoman. Ms. Rikkers has served as Director and Co-founder of ProSomnus Sleep Technologies since 2016, including serving as Chairman from 2016 to 2018 and 2019 to 2021, and Executive Chairman January 2022 to October 2023. Ms. Rikkers has served as Managing Director of HealthpointCapital LLC, a private equity firm and manager of the principal stockholders of ProSomnus, since 2004 and Managing Director of HealthpointCapital Management LLC from 2018 to 2022. Ms. Rikkers served as director of MicroDental Laboratories and BioHorizons Inc., a joint venture with Henry Schein Inc., and as a board observer for multiple growth stage, dental and healthcare companies. She received her BA from Harvard University and her MA degree from Teachers College, Columbia University.

Len Liptak, Chief Executive Officer and Director. Mr. Liptak has served as CEO, Co-founder and Director of ProSomnus Sleep Technologies since 2016, where he has overseen operations, strategy and financial performance of ProSomnus. From 2011 to 2016, Mr. Liptak served as President of MicroDental Laboratories, a network of dental labs that fabricate high-quality dental restorations and appliances, until its successful sale to Modern Dental Group. Prior to that, Mr. Liptak served in marketing at Stryker Neurovascular and a variety of roles at 3M, including Global Business Manager. Mr. Liptak earned his BA from Brown University and MBA from the University of Minnesota, Carlson School of Management.

Len Hedge, Director and member of the Compensation and Nomination and Corporate Governance Committees. Mr. Hedge has served as a member of the Board of Directors of Convergent Dental, a privately owned dental equipment and technology company, since 2013, and as a member of the board of directors of ProSomnus Sleep Technologies since 2016. He formerly served as a director at MicroDental Laboratories, OrthoAccel, a privately owned dental device company, and Six Month Smiles, a private company providing dental aligners and braces. Prior to his retirement, Mr. Hedge served as Senior Vice President of Business Operations at Align Technology Inc. from 2007 to 2013. Mr. Hedge focused on the design and implementation of core business processes and cross-functional collaboration to support Align’s long-term goals and strategic initiatives. He served as Vice President of Operations at Align from 2002 to 2007 and also served as its Vice President of Manufacturing … from 1999 to 2002 and helped create Align’s world-class mass customized manufacturing technology and processes. He served as Vice President of Operations for Plynetics Express Corporation, a leading provider of product development and engineering services, from 1996 to 1998. From 1991 to 1996, he led the accelerated product development initiative at Beckman Instruments Diagnostic Systems Group as Manager for Prototype Manufacturing and Process Development. Prior to Beckman, Mr. Hedge led mechanical fabrication operations for 13 years at General Dynamics in Pomona California. Mr. Hedge received his BS from La Verne University.

Heather Rider, Director, Chairman of the Compensation Committee and member of the Nomination and Corporate Governance Committee. Ms. Rider has served on the board of directors of Intricon Corporation (Nasdaq: IIN), a joint development manufacturer of components for micro-medical technology, from 2020 to 2022, and has served on the board of directors of Inogen, Inc. (Nasdaq: INGN), a manufacturer of oxygen therapy technology, since 2014. From 2012 to 2013, Ms. Rider served as Vice President, Global Human Resources of Cymer, Inc., a publicly-traded supplier of light sources for semiconductor manufacturing that was acquired by ASML Holding NV in 2013. From October 2010 to September 2012, Ms. Rider served as Senior Vice President, Global Human Resources of Alphatec Holdings, Inc. (Nasdaq: ATEC), a medical device company focused on surgical treatment of spine disorders, and from 2006 to 2010, she served as Vice President, Human Resources of Intuitive Surgical, Inc. (Nasdaq: ISRG), a manufacturer of robotic surgical systems. From 2001 to 2005, Ms. Rider served as Senior Vice President of Global Human Resources of Sunrise Medical, Inc., a global manufacturer and distributor of durable medical equipment. From 1998 to 2001, Ms. Rider served as Vice President of Human Resources of Biosense Webster, a member of the Johnson & Johnson family of companies, and a medical device manufacturer. Ms. Rider earned her BA from Claremont McKenna College, and her MBA from Pepperdine Graziadio Business School.

Bill Johnson, Director and Chairman of the Audit Committee. Mr. Johnson has served as Director of ProSomnus Sleep Technologies since 2016, including serving as Chairman from 2018 to 2019 and has served as Chairman of the Audit Committee for ProSomnus Sleep Technologies from 2016 to 2018 and 2019 to present, and has been the Managing Director and Chief Financial Officer of HealthpointCapital Management, LLC since 2016. Mr. Johnson served as the Chief Executive Officer of MicroDental, Inc. from 2015 to 2016, and the Chief Financial Officer of MicroDental from 2013 to 2015. Mr. Johnson served as Chief Financial Officer for Harvest Meat from 2012 to 2013, interim Chief Financial Officer for Ryerson Inc. in 2012, Chief Financial Officer for Brinderson Engineers & Construction from 2009 to 2011, Chief Financial Officer of PNA Group in 2008 and SVP of Finance from 2007 to 2008. Earlier in his career, Mr. Johnson worked in a variety of roles at companies responsible for financial reporting and accounting, and began his career at Ernst & Whinney, CPA’s (now Ernst & Young) as an auditor. Mr. Johnson earned BS from Indiana University, Kelley School of Business, and his MBA with a concentration in Finance from Mercer University, Stetson School of Business. He is a Certified Public Accountant and a Certified Financial Planner. 

Steven Pacelli, Director, Chairman of the Nomination and Corporate Governance Committee and member of the Audit Committee. Mr. Pacelli has held a variety of roles at Dexcom Ventures, including Executive Vice President and Managing Director since 2021, Executive Vice President of Strategy and Corporate Development from 2012 to 2021 and a variety of other roles since 2006. Prior to Dexcom, Steve served as a corporate attorney specializing in finance, mergers and acquisitions, and general corporate matters, and in an executive role as general counsel of several privately held companies. Mr. Pacelli serves on the board of directors of Biocom California, the largest and most experienced leader and advocate for California’s life science sector, and on the boards of directors of several nonprofit organizations and trade groups. Mr. Pacelli earned a BS from the University of California, Los Angeles, and a JD from the University of Virginia. He is a member of the State Bar of California.

Jason Orchard, Director and member of the Audit Committee. Mr. Orchard has been with Spring Mountain Capital (“SMC”), a private investment management firm specializing in alternative asset investing, since 2004 and has served as a Managing Director since 2008. During his time at SMC he has served as Investment Analyst, Chief Financial Officer, and Portfolio Manager. In 2007, he led the firm’s initial efforts into special situation and thematic investments that have become the foundation of the SMC Total Return Fund. Today, he manages the SMC Total Return Fund and serves on the Investment Committee for the SMC’s Total Return Fund, Private Capital Fund, and West Harlem Innovation Fund. Prior to joining SMC in 2004, he was a Senior Analyst for Rutherford Asset Management LLC, which actively managed an $800 million hedge fund of funds portfolio for a private family office. Mr. Orchard has also been associated with Stern Stewart & Company as a Senior Analyst in the Financial Institutions Group and Arthur Andersen, L.L.P. as a Senior Consultant in the Strategy, Finance, and Economics Group. Mr. Orchard graduated with honors from Villanova University with a BS in Finance and is a Chartered Financial Analyst.

Contact Us

ProSomnus Sleep Technologies

Send Us a Message.

Ready, Set, SLEEP.

Create better outcomes and happier
patients with ProSomnus.
Get Started
  • United States

Privacy Policy

Len Liptak

Co-founder & Chief Executive Officer

Len Liptak is the CEO of ProSomnus® Sleep Technologies. An award-winning executive with expertise growing and operating innovation-oriented businesses, Len is a founding member of ProSomnus, and co-inventor of the company’s flagship product. Len also serves on the company’s Board of Directors.

Prior to starting ProSomnus, Len was President of MicroDental Laboratories, where he led the commercialization of multiple, award-winning, new products, guided business unit operations, and directed the expansion of the company’s digital supply chain. During Len’s tenure, the company grew three times faster than the industry average, expanded gross margins, and set company records for profitability. At MicroDental, Len was named to ExecRank’s list of top executives for privately held companies in 2012 and 2013. In 2016, Len led the sale of MicroDental Laboratories to the Modern Dental Group (HKG:3600).

Len also spent 10 years at 3M Company and Stryker Corporation in strategic business development, business unit management and product development capacities. While at 3M, Len received his Six Sigma accreditation, and was awarded the company’s Golden Step Award, Circle of Technical Excellence Team Award, and Global Sales and Marketing Leadership Award.

Len earned an M.B.A. from the University of Minnesota’s Carlson School of Management and a B.A. from Brown University. A lifelong learner, Len has completed executive education programs at John’s Hopkins, and is a member of the Young President’s Organization (YPO).

Sung Kim

Co-founder & Chief Technology Officer

Sung Kim is the Chief Technology Officer for ProSomnus® Sleep Technologies. Prior to starting ProSomnus, Sung was Engineering Director of MicroDental Laboratories and was responsible for product and process development projects including the MicrO2® Sleep and Snore Device.

Before MicroDental Laboratories, Sung worked for 3M Company for over 7 years holding several senior level product development and engineering positions and has either authored or co-authored a number of patents related to the dental and orthodontic industries. Sung was a Circle of Technical Excellence Individual Winner in 3M Health Care Business.

Sung holds a Bachelor of Science degree in Mechanical Engineering from California Polytechnic State University, San Luis Obispo.

Brian Dow

Chief Financial Officer

Brian Dow is the Chief Financial Officer for ProSomnus® Sleep Technologies. Prior to joining ProSomnus in March of 2023, Mr. Dow served as Chief Financial Officer of Agendia N.V., a $60 million molecular diagnostics company, Senior Vice President and Chief Financial Officer of Pulse Biosciences (NASDAQ: PLSE), a development stage medical device company, and Principal Accounting Officer for Pacific Biosciences (NASDAQ: PACB), a commercial stage developer, manufacturer and provider of next generation sequencing instruments. Mr. Dow started his career as a manager with Ernst & Young.

Mr. Dow holds a B.S. in Management from the Georgia Institute of Technology and is recognized as a licensed certified public accountant by the Washington State Board of Accountancy.

Dr. Mark T. Murphy, DDS, D-ABDSM

Lead Faculty Clinical Education

Mark T. Murphy, DDS, a Diplomate of the American Board of Dental Sleep Medicine is the Lead Faculty for Clinical Education at ProSomnus® Sleep Technologies and the Principal of Funktional Consulting . He also serves on the Adjunct Faculty at the University of Detroit Mercy and oversees the Practice and Financial Management Curriculum at the Pankey Institute. He lectures internationally on Leadership, Practice Management, Communication, Case Acceptance, Planning, Occlusion, TMD and Obstructive Sleep Apnea. Mark has been involved in Sleep Dentistry for over 25 years, is an AADSM member, and has trained with several of the leading sleep dentists and training institutes. He is an informative and entertaining speaker, blending a stand-up style of humor and anecdotes with current evidence-based research that you can take home and use in your practice right away.

Heather Whalen

Vice President, Global Marketing Services

Heather Whalen is the VP, Global Marketing Services for ProSomnus Sleep Technologies. Prior to joining ProSomnus, Heather was Director of Clinical Education for MicroDental Laboratories and was responsible for all educational activities including management of ADA CERP recognition, sponsorships, affiliations and managing over 100 events per year.

Heather spent over 13 years at MicroDental holding other various management roles leading successful teams in Sales and Customer Service. Previously, Heather worked for San Francisco Bay Area Graphic Design firms in Project Management. Heather holds a Bachelor of Arts Degree in Communication Design from California State University, Chico.

Jerry Vogel

Vice President, Sales Trainer

Jerry Vogel has 40 years of sales and executive leadership in the medical and dental industry. He specializes in Patient Focused Sleep and Digital Solutions. Jerry was responsible for sales and management in both North and Latin America for Nobel Biocare. He also had leadership roles at Masimo Corporation, Pyxis and Panthera Dental.

Jerry has lectured nationally at many major meetings discussing the practice development formulas for both sleep and digital dentistry. He is the President of the Drew O’Donoghue Fund, a non-profit organization dedicated to research, cures and awareness of rare cancers, particularly ACC. He has been honored as the citizen of the year from his town and the recipient of the volunteer of the year for Bergen County.

Jerry is a sleep apnea patient himself and is committed to helping the millions of CPAP failure and untreated patients. He aspires to identify a pediatric appliance solution to assist children with this epidemic, especially those classified within the Spectrum.

Dr. John E. Remmers, MD

Chief Scientist

Dr. John E. Remmers is a world-renowned expert in the field of snoring and sleep apnea, being the first researcher to elucidate the pathogenesis of sleep apnea and to demonstrate that sleep apnea is caused by an anatomical narrowing of the pharynx.

As a recognized pioneer and innovator in sleep medicine, Dr. Remmers has invented products ranging from portable diagnostic sleep monitors to auto-titrating CPAP devices, including proactive algorithms to automatically adjust CPAP pressure based on patient need.

Dr. Remmers served two terms as the Editor-in-Chief of the Journal of Applied Physiology and has presented honorary research lectures to the American Thoracic Society, the American Physiological Society and American College of Chest Physicians. His research interests relate to the neurobiology of respiratory rhythmogenesis, chemoreception, and the pathophysiology of the control of breathing. Dr. Remmers has published over one hundred peer reviewed publications in the area of respiratory physiology. 

Dr. Remmers is a pulmonologist and professor emeritus of internal medicine at the University of Calgary. Dr. Remmers founded the sleep lab at the Foothills Medical Centre in Calgary in 1984 and is the Chief Scientist of ProSomnus® Sleep Technologies.

Dr. Edward T. Sall, MD, DDS, MBA

Medical Director

Dr. Edward T. Sall is Medical Director for ProSomnus® Sleep Technologies. As Medical Director, Dr. Sall focuses on enhancing physician acceptance of Oral Appliance Therapy for patients with Obstructive Sleep Apnea.

He obtained a DDS from Columbia University School of Dental and Oral Surgery in 1980. Due to his interest in facial pain and temporomandibular disorders he decided to return to medical school for additional training. He attended SUNY Upstate Medical Center and received an MD in 1987, followed by a 5-year residency in Otolaryngology/Head and Neck Surgery. Since 1992, Dr. Sall has practiced in Syracuse, New York as an Otolaryngologist and Dentist with an emphasis on TMD, facial pain, general Otolaryngology and the surgical and medical management of sleep disorders. He obtained an MBA from SUNY Binghamton in 2000 with an emphasis in healthcare. Dr. Sall became board certified in Sleep Medicine and has treated over 3,500 patients with Oral Appliance Therapy.

Dr. Shouresh Charkhandeh, DDS, BMedSc

Global Scientific Committee Chair

Dr. Shouresh Charkhandeh is the Global Scientific Committee Chair for ProSomnus® Sleep Technologies. Within his role, Dr. Charkhandeh works with leading clinicians around the world to assess and design relevant research to best serve patients suffering from OSA and to answer critical questions clinicians have in case selection amongst many therapies offered for the treatment of OSA.

Dr. Charkhandeh received his Doctor of Dental Surgery (DDS) Degree and Bachelor of Medical Sciences from the University of Alberta, Canada. He also earned fellowships from International Association of Physiologic Aesthetics & Las Vegas Institute for Advanced Dental Studies.

He then furthered his education and training by completing a Research Fellowship in the area of “Sleep and Dental Sleep Medicine” at the University of Antwerp Hospital (UZA), in Antwerp, Belgium, where he is also currently working on his PhD.

As a well-known and passionate educator, researcher and innovator in dental sleep medicine, Dr. Charkhandeh has lectured at numerous national sleep meetings across the world, such as AASM & AADSM Annual Meetings (USA), CSS Annual Meeting (Canada), iBEDSMA Annual Meeting (Belgium), NVTS Annual Meeting (Netherlands), DGZS Annual Meeting (Germany), SBOE Annual Meeting (Brazil) and many more dental meetings.

He is the recipient of the “2012 & 2015 Clinical Research Award” and “2015 Clinical Excellence Award” from the American Academy of Dental Sleep Medicine.

Dr. Charkhandeh is a general dentist who is actively involved in clinical research in Dental Sleep Medicine and his research focuses on developing new technologies to improve treatment outcome predictability and patient selection in Oral Appliance Therapy for patients with OSA (i.e. Obstructive Sleep Apnea) and improving clinical workflow efficiencies, utilizing different digital technologies.

Erin Mosca

Director of Medical Affairs

Erin Mosca is the Director of Medical Affairs for ProSomnus Sleep Technologies. Erin has over a decade of experience in the fields of respiratory neurophysiology and sleep medicine. Prior to joining ProSomnus, Erin was the Director of Technology and Regulatory for Zephyr Sleep Technologies. At Zephyr, Erin was involved in design, validation, and regulatory activities for a number of medical devices, including home sleep apnea test and novel auto-titration devices as well as temporary oral appliances and other dental sleep medicine tools. Erin also has experience working in clinical drug trials and as a medical writer in early phase drug development. Erin completed a BSc in Neuroscience at the University of Lethbridge and a PhD in Neuroscience at the University of Calgary.

Len Liptak

Len Liptak, Chief Executive Officer and Director. Mr. Liptak has served as CEO, Co-founder and Director of ProSomnus Sleep Technologies since 2016, where he has overseen operations, strategy and financial performance of ProSomnus. From 2011 to 2016, Mr. Liptak served as President of MicroDental Laboratories, a network of dental labs that fabricate high-quality dental restorations and appliances, until its successful sale to Modern Dental Group. Prior to that, Mr. Liptak served in marketing at Stryker Neurovascular and a variety of roles at 3M, including Global Business Manager. Mr. Liptak earned his BA from Brown University and MBA from the University of Minnesota, Carlson School of Management.

Laing Rikkers

Laing Rikkers, Chairwoman. Ms. Rikkers has served as Director and Co-founder of ProSomnus Sleep Technologies since 2016, including serving as Chairman from 2016 to 2018 and 2019 to 2021, and Executive Chairman January 2022 to October 2023. Ms. Rikkers has served as Managing Director of HealthpointCapital LLC, a private equity firm and manager of the principal stockholders of ProSomnus, since 2004 and Managing Director of HealthpointCapital Management LLC from 2018 to 2022. Ms. Rikkers served as director of MicroDental Laboratories and BioHorizons Inc., a joint venture with Henry Schein Inc., and as a board observer for multiple growth stage, dental and healthcare companies. She received her BA from Harvard University and her MA degree from Teachers College, Columbia University.

Len Hedge

Len Hedge, Director and member of the Compensation and Nomination and Corporate Governance Committees. Mr. Hedge has served as a member of the Board of Directors of Convergent Dental, a privately owned dental equipment and technology company, since 2013, and as a member of the board of directors of ProSomnus Sleep Technologies since 2016. He formerly served as a director at MicroDental Laboratories, OrthoAccel, a privately owned dental device company, and Six Month Smiles, a private company providing dental aligners and braces. Prior to his retirement, Mr. Hedge served as Senior Vice President of Business Operations at Align Technology Inc. from 2007 to 2013. Mr. Hedge focused on the design and implementation of core business processes and cross-functional collaboration to support Align’s long-term goals and strategic initiatives. He served as Vice President of Operations at Align from 2002 to 2007 and also served as its Vice President of Manufacturing … from 1999 to 2002 and helped create Align’s world-class mass customized manufacturing technology and processes. He served as Vice President of Operations for Plynetics Express Corporation, a leading provider of product development and engineering services, from 1996 to 1998. From 1991 to 1996, he led the accelerated product development initiative at Beckman Instruments Diagnostic Systems Group as Manager for Prototype Manufacturing and Process Development. Prior to Beckman, Mr. Hedge led mechanical fabrication operations for 13 years at General Dynamics in Pomona California. Mr. Hedge received his BS from La Verne University.

Heather Rider

Heather Rider, Director, Chairman of the Compensation Committee and member of the Nomination and Corporate Governance Committee. Ms. Rider has served on the board of directors of Intricon Corporation (Nasdaq: IIN), a joint development manufacturer of components for micro-medical technology, from 2020 to 2022, and has served on the board of directors of Inogen, Inc. (Nasdaq: INGN), a manufacturer of oxygen therapy technology, since 2014. From 2012 to 2013, Ms. Rider served as Vice President, Global Human Resources of Cymer, Inc., a publicly-traded supplier of light sources for semiconductor manufacturing that was acquired by ASML Holding NV in 2013. From October 2010 to September 2012, Ms. Rider served as Senior Vice President, Global Human Resources of Alphatec Holdings, Inc. (Nasdaq: ATEC), a medical device company focused on surgical treatment of spine disorders, and from 2006 to 2010, she served as Vice President, Human Resources of Intuitive Surgical, Inc. (Nasdaq: ISRG), a manufacturer of robotic surgical systems. From 2001 to 2005, Ms. Rider served as Senior Vice President of Global Human Resources of Sunrise Medical, Inc., a global manufacturer and distributor of durable medical equipment. From 1998 to 2001, Ms. Rider served as Vice President of Human Resources of Biosense Webster, a member of the Johnson & Johnson family of companies, and a medical device manufacturer. Ms. Rider earned her BA from Claremont McKenna College, and her MBA from Pepperdine Graziadio Business School.

Bill Johnson

Bill Johnson, Director and Chairman of the Audit Committee. Mr. Johnson has served as Director of ProSomnus Sleep Technologies since 2016, including serving as Chairman from 2018 to 2019 and has served as Chairman of the Audit Committee for ProSomnus Sleep Technologies from 2016 to 2018 and 2019 to present, and has been the Managing Director and Chief Financial Officer of HealthpointCapital Management, LLC since 2016. Mr. Johnson served as the Chief Executive Officer of MicroDental, Inc. from 2015 to 2016, and the Chief Financial Officer of MicroDental from 2013 to 2015. Mr. Johnson served as Chief Financial Officer for Harvest Meat from 2012 to 2013, interim Chief Financial Officer for Ryerson Inc. in 2012, Chief Financial Officer for Brinderson Engineers & Construction from 2009 to 2011, Chief Financial Officer of PNA Group in 2008 and SVP of Finance from 2007 to 2008. Earlier in his career, Mr. Johnson worked in a variety of roles at companies responsible for financial reporting and accounting, and began his career at Ernst & Whinney, CPA’s (now Ernst & Young) as an auditor. Mr. Johnson earned BS from Indiana University, Kelley School of Business, and his MBA with a concentration in Finance from Mercer University, Stetson School of Business. He is a Certified Public Accountant and a Certified Financial Planner. 

Steven Pacelli

Steven Pacelli, Director, Chairman of the Nomination and Corporate Governance Committee and member of the Audit Committee. Mr. Pacelli has held a variety of roles at Dexcom Ventures, including Executive Vice President and Managing Director since 2021, Executive Vice President of Strategy and Corporate Development from 2012 to 2021 and a variety of other roles since 2006. Prior to Dexcom, Steve served as a corporate attorney specializing in finance, mergers and acquisitions, and general corporate matters, and in an executive role as general counsel of several privately held companies. Mr. Pacelli serves on the board of directors of Biocom California, the largest and most experienced leader and advocate for California’s life science sector, and on the boards of directors of several nonprofit organizations and trade groups. Mr. Pacelli earned a BS from the University of California, Los Angeles, and a JD from the University of Virginia. He is a member of the State Bar of California.

Jason Orchard

Jason Orchard, Director and member of the Audit Committee. Mr. Orchard has been with Spring Mountain Capital (“SMC”), a private investment management firm specializing in alternative asset investing, since 2004 and has served as a Managing Director since 2008. During his time at SMC he has served as Investment Analyst, Chief Financial Officer, and Portfolio Manager. In 2007, he led the firm’s initial efforts into special situation and thematic investments that have become the foundation of the SMC Total Return Fund. Today, he manages the SMC Total Return Fund and serves on the Investment Committee for the SMC’s Total Return Fund, Private Capital Fund, and West Harlem Innovation Fund. Prior to joining SMC in 2004, he was a Senior Analyst for Rutherford Asset Management LLC, which actively managed an $800 million hedge fund of funds portfolio for a private family office. Mr. Orchard has also been associated with Stern Stewart & Company as a Senior Analyst in the Financial Institutions Group and Arthur Andersen, L.L.P. as a Senior Consultant in the Strategy, Finance, and Economics Group. Mr. Orchard graduated with honors from Villanova University with a BS in Finance and is a Chartered Financial Analyst.

Applicant Form

Thank you for your interest in ProSomnus career opportunities. Please choose your department of interest:

Resume Upload

By submitting this form, you may be contacted by our staff to verify information.

Cookies on ProSomnus.com

This site uses cookies to provide the best possible user experience. This includes features to measure performance, reliability, and overall site health. By continuing on to use the site, you agree to accept these cookies. 

Accept All

Request Your Provider Portal Login Credentials

Please complete the form. A ProSomnus team member will reach out to you with your unique login credentials.

Request an Appointment